Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatrics ; 151(6)2023 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-37232099

RESUMO

Childhood interstitial lung disease (chILD) is a collective term for a group of rare lung disorders of heterogeneous origin. Surfactant dysfunction disorders are a cause of chILD with onset during the neonatal period and infancy. Clinical signs of tachypnea and hypoxemia are nonspecific and usually caused by common conditions like lower respiratory tract infections. We report on a full-term male newborn who was readmitted to the hospital at 7 days of age with marked tachypnea and poor feeding during the respiratory syncytial virus season. After exclusion of infection and other, more common congenital disorders, chILD was diagnosed using chest computed tomography and genetic analysis. A likely pathogenic heterozygous variant of SFTPC (c.163C>T, L55F) was detected by whole exome sequencing. The patient received supplemental oxygen and noninvasive respiratory support and was treated with intravenous methylprednisolone pulses and hydroxychloroquine. Despite the treatment, his respiratory situation deteriorated continuously, leading to several hospitalizations and continuous escalation of noninvasive ventilatory support. At 6 months of age, the patient was listed for lung transplant and transplanted successfully aged 7 months.


Assuntos
Doenças Pulmonares Intersticiais , Proteína C , Humanos , Lactente , Recém-Nascido , Masculino , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/genética , Doenças Pulmonares Intersticiais/terapia , Mutação , Proteína C/genética , Proteína C/uso terapêutico , Proteína C Associada a Surfactante Pulmonar/genética , Proteína C Associada a Surfactante Pulmonar/uso terapêutico , Tensoativos , Taquipneia
3.
J Pediatr Endocrinol Metab ; 26(5-6): 569-74, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23412866

RESUMO

The tricarboxylic acid (TCA) cycle represents the key enzymatic steps in cellular energy metabolism. Once the TCA cycle is impaired in case of inherited metabolic disorders, life-threatening episodes of metabolic decompensation and severe organ failure can arise. We present the case of a 6 ½-year-old girl with propionic acidaemia during an episode of acute life-threatening metabolic decompensation and severe lactic acidosis. Citric acid given as an oral formulation showed the potential to sustain the TCA cycle flux. This therapeutic approach may become a treatment option in a situation of acute metabolic crisis, possibly preventing severe disturbance of energy metabolism.


Assuntos
Ciclo do Ácido Cítrico/efeitos dos fármacos , Ácido Cítrico/uso terapêutico , Acidemia Propiônica/tratamento farmacológico , Acidemia Propiônica/metabolismo , Doença Aguda , Anticoagulantes/uso terapêutico , Criança , Estado Terminal , Metabolismo Energético/efeitos dos fármacos , Feminino , Humanos , Resultado do Tratamento
4.
J Pediatr Hematol Oncol ; 34(2): e80-3, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22134616

RESUMO

Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and its prognosis has considerably improved over the past 2 decades due to new therapeutic approaches. In some cases, however, it can develop very rapidly and cause possibly fatal complications. We report on the case of an 11-year-old boy with ALL, who rapidly developed severe lactic acidosis and abdominal compartment syndrome. He died of multiorgan failure only 5 days after diagnosis of ALL had been established. Autopsy revealed systemic leukemic infiltrations. We suppose that the mass of tumor cells induced a cascade of metabolic and endocrine reactions, which not only triggered the rapid progression of the disease but were also accountable for the lack of response to treatment. The pathophysiology of abdominal compartment syndrome as a rare and in our case ultimately fatal complication of ALL is described.


Assuntos
Acidose Láctica/etiologia , Hipertensão Intra-Abdominal/etiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Acidose Láctica/fisiopatologia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Evolução Fatal , Humanos , Hipertensão Intra-Abdominal/fisiopatologia , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/fisiopatologia , Ensaios Clínicos Controlados Aleatórios como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...